Ten years' disease-free survival of advanced epithelial ovarian cancer treated by cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy A case report and literature review

被引:2
|
作者
Zhang, Jue [1 ]
Mei, Liejun [2 ]
Wang, Fubing [3 ]
Li, Yan [1 ]
机构
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Peritoneal Canc Surg, 10 Tieyi Rd,Yangfangdian St, Beijing 100038, Peoples R China
[2] Wuhan Univ, Zhongnan Hosp, Dept Radiol, Wuhan 430071, Peoples R China
[3] Wuhan Univ, Zhongnan Hosp, Dept Clin Lab, Wuhan 430071, Peoples R China
基金
北京市自然科学基金;
关键词
advanced ovarian cancer; cytoreductive surgery; hyperthermic intraperitoneal chemotherapy; peritoneal carcinomatosis; HIPEC; PACLITAXEL; CISPLATIN;
D O I
10.1097/MD.0000000000023404
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: One of the most distinctive features of epithelial ovarian cancer is tendency to disseminate into peritoneal cavity to form peritoneal carcinomatosis, indicating advanced disease with poor prognosis. Patient concerns: A fifty-year-old patient had a chief complaint of an abdominal distension lasting 1 month. Diagnoses: The patient was diagnosed with advanced epithelial ovarian cancer with peritoneal carcinomatosis by computed tomography scan, tumor markers, endoscopy examination, and pathology. Interventions: The patient was treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy followed by 8 cycles of systemic chemotherapy. Outcomes: Till March 9, 2020, the patient has disease-free survival over 10 years. Lessons: The application of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy combined with systematic chemotherapy may improve survival dramatically for the patients with epithelial ovarian cancer and peritoneal carcinomatosis and should be considered as an option of a relatively new regime.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Associated with Cytoreductive Surgery in the Treatment of Advanced Ovarian Cancer: Systematic Review and Meta-Analysis
    Llueca, Maria
    Ibanez, Maria Victoria
    Climent, Maria Teresa
    Serra, Anna
    Llueca, Antoni
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (02):
  • [22] Secondary Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy for Advanced or Recurrent Mucinous Ovarian Cancer
    Conley, Aliyah B.
    Fournier, Keith F.
    Sood, Anil K.
    Frumovitz, Michael
    OBSTETRICS AND GYNECOLOGY, 2023, 141 (05) : 1019 - 1023
  • [23] Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary and recurrent advanced ovarian cancer
    Cascales Campos, P.
    Gil, Jose
    Parrilla, Pascual
    EJSO, 2014, 40 (08): : 970 - 975
  • [24] Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in Ovarian Cancer: An Umbrella Review of Meta-Analyses
    Souadka, Amine
    Essangri, Hajar
    Majbar, Mohammed Anass
    Benkabbou, Amine
    Boutayeb, Saber
    You, Benoit
    Glehen, Olivier
    Mohsine, Raouf
    Bakrin, Naoual
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [25] The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
    Zhang, Guyu
    Zhu, Yimin
    Liu, Chongdong
    Chao, Guangming
    Cui, Ran
    Zhang, Zhenyu
    JOURNAL OF OVARIAN RESEARCH, 2019, 12 (1)
  • [26] The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
    Guyu Zhang
    Yimin Zhu
    Chongdong Liu
    Guangming Chao
    Ran Cui
    Zhenyu Zhang
    Journal of Ovarian Research, 12
  • [27] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Urothelial Origin: a Case Report and Literature Review
    Blanca Rufián-Andújar
    Francisca Valenzuela-Molina
    Lidia Rodríguez-Ortiz
    Sebastián Rufián-Peña
    Francisco Javier Briceño-Delgado
    Álvaro Arjona-Sánchez
    Indian Journal of Surgical Oncology, 2023, 14 : 106 - 108
  • [28] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial and recurrent ovarian carcinoma: a single center experience
    Pavlov, Maja J.
    Ceranic, Miljan S.
    Latincic, Stojan M.
    Sabljak, Predrag V.
    Kecmanovic, Dragutin M.
    Sugarbaker, Paul H.
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2018, 34 (05) : 564 - 569
  • [29] The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of recurrent advanced ovarian cancer: a prospective study
    Spiliotis, J.
    Vaxevanidou, A.
    Sergouniotis, F.
    Lambropoulou, E.
    Datsis, A.
    Christopoulou, A.
    JOURNAL OF BUON, 2011, 16 (01): : 74 - 79
  • [30] Perianesthesia Measurement During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Procedure: A Case Report and Review of the Literature
    Li, Dan
    Henker, Richard
    Zhang, Fei
    JOURNAL OF PERIANESTHESIA NURSING, 2019, 34 (01) : 198 - 205